Drug profile · INN
permethrin
LYCLEAR
permethrin (LYCLEAR) is a voltage-sensitive sodium channel blocker. Route of administration: topical. Current US regulatory status: approved.
Drug details — permethrin
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 3
- Programs
- 3
- Data quality
- 0.84
Quick answer
permethrin (LYCLEAR) is a voltage-sensitive sodium channel blocker. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-sensitive sodium channel blocker
Primary target: Voltage-sensitive sodium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is permethrin?
permethrin (LYCLEAR) is a voltage-sensitive sodium channel blocker. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for permethrin?
LYCLEAR is a marketed brand name for permethrin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of permethrin?
permethrin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.